Lyra Therapeutics Inc.

NASDAQ: LYRA · Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.91
-2.12%
After-hours: Aug 15, 2025, 04:40 PM EDT

Lyra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-93.44M -62.68M -55.28M -43.51M
Depreciation & Amortization
471K 278K 1.07M 1M
Stock-Based Compensation
6.72M 5.89M 5.45M 2.77M
Other Working Capital
-4.46M -5.33M 6.97M 11.57M
Other Non-Cash Items
22.58M -1.9M 824K 2.42M
Deferred Income Tax
n/a n/a n/a -2.42M
Change in Working Capital
-6.35M -4.88M 4.55M 13.92M
Operating Cash Flow
-70.01M -63.3M -43.38M -25.82M
Capital Expenditures
-2.34M -1.05M -164K -3.38M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-47.95M -122.42M -64.84M n/a
Sales Maturities Of Investments
130.59M 110.89M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
80.31M -12.58M -65.01M -3.38M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-287K -3.55M -4.24M -245K
Financial Cash Flow
8.53M 65.69M 96.26M 359K
Net Cash Flow
18.82M -10.2M -12.13M -28.85M
Free Cash Flow
-72.35M -64.35M -43.55M -29.2M